Fabenol Max
Also known as: Phaseolus vulgaris extract, Common bean extract, α-amylase inhibitor, Fabenol Max
Overview
Fabenol Max is an aqueous extract derived from *Phaseolus vulgaris* L., commonly known as the kidney bean. It is primarily standardized for its α-amylase inhibitory activity, making it a dietary supplement aimed at reducing carbohydrate absorption. The supplement is marketed to assist in managing carbohydrate intake and potentially aid in maintaining healthy blood sugar levels. Although the specific research on Fabenol Max is limited, studies on extracts of *Phaseolus vulgaris* support some health benefits, including cardiovascular health improvement and glucose management. Its defining characteristic is its ability to inhibit α-amylase, an enzyme vital for carbohydrate digestion. Overall, while promising, the clinical evidence specific to Fabenol Max requires further investigation.
Benefits
The primary claimed benefit of Fabenol Max is the reduction of carbohydrate absorption; however, the evidence supporting this claim is insufficient. In contrast, studies on common bean extracts have indicated potential benefits such as a 19% reduction in LDL cholesterol and improvements in cardiovascular health. Some research suggests that common beans could help reduce the risk of cardiovascular disease and improve postprandial glucose levels. Notably, these benefits appear particularly relevant for individuals managing their carbohydrate intake or those at risk for cardiovascular diseases. Yet, specific data regarding Fabenol Max's efficacy remains limited, indicating the need for additional clinical studies.
How it works
Fabenol Max works primarily through the inhibition of α-amylase, an enzyme responsible for breaking down carbohydrates in the digestive system. By reducing the activity of this enzyme, Fabenol Max theoretically lowers the digestion and absorption of carbohydrates, which may yield beneficial effects on blood sugar levels. Despite this proposed mechanism, specific information regarding the absorption and bioavailability of Fabenol Max remains unestablished.
Side effects
Fabenol Max, like other extracts from *Phaseolus vulgaris*, is generally considered safe, although specific safety data for this supplement is limited. Common side effects are not well-documented, though gastrointestinal discomfort may occur due to its mechanism of action. Rare side effects have not been reported. Users should be cautious of potential interactions with diabetes medications, as the supplement may affect carbohydrate metabolism. It is recommended that individuals with diabetes consult a healthcare provider before use. Furthermore, pregnant or breastfeeding women are advised to seek medical guidance due to a lack of comprehensive data on safety within these populations.
Dosage
There are no established minimum effective doses or optimal dosage ranges for Fabenol Max. It should ideally be taken before meals if the goal is to reduce carbohydrate absorption. The form of the supplement is typically capsules or tablets, but specific absorption factors are not well-studied. As of now, a maximum safe dose has not been determined, highlighting the need for further research. No required cofactors have been documented to enhance its effects.
FAQs
Can I take Fabenol Max if I am on diabetes medication?
It’s crucial to consult healthcare providers if you're on diabetes medication, as Fabenol Max may affect carbohydrate absorption.
Is Fabenol Max safe for everyone?
While generally safe, those with diabetes, pregnant, or breastfeeding should consult healthcare providers due to limited safety data.
When is the best time to take Fabenol Max?
Fabenol Max should be taken before meals to potentially reduce carbohydrate absorption.
What results can I expect from taking Fabenol Max?
Expected benefits for Fabenol Max are not well-supported by evidence; specific results may vary among individuals.
Is Fabenol Max effective for weight loss?
Fabenol Max is not a proven weight loss aid; it may help manage carbohydrate intake but is not guaranteed for weight loss.
Research Sources
- https://www.efsa.europa.eu/en/efsajournal/pub/4401 – The European Food Safety Authority (EFSA) concluded that there was insufficient evidence to support the claim that Fabenol Max reduces carbohydrate absorption, indicating a need for more robust studies.
- https://www.mdpi.com/2072-6643/13/11/3701 – This systematic review highlights that common beans can reduce LDL cholesterol levels by 19%, decrease cardiovascular disease risk by 11%, and coronary heart disease risk by 22%, providing a basis for potential health benefits from *Phaseolus vulgaris*.
- https://pubmed.ncbi.nlm.nih.gov/38956175/ – A meta-analysis associated legume consumption, including common beans, with reduced cardiovascular disease risk and improved glycemic control, although it does not specifically address Fabenol Max.
- https://pubmed.ncbi.nlm.nih.gov/39669830/ – Further research into legume consumption suggests health benefits, including improvements in metabolic parameters; however, again, studies on Fabenol Max specifically are lacking.
- https://fabenol.com/benefits/clinical-studies/ – The web resource outlines clinical studies conducted on Fabenol Max, although it emphasizes the need for more extensive research to firmly establish efficacy.
